Platelet Rich Plasma Market Poised for Significant Growth Accelerated by Technological Advancements
![]() |
Platelet Rich Plasma Market |
Platelet
Rich Plasma (PRP) is derived from whole blood with high platelet concentration
and holds tremendous growth potential in therapeutics and regenerative
medicine. It is collected from patient’s own blood and then used for treating
chronic tendinopathy, joint pain, knee cartilage and acromioclavicular joint
injuries. PRP therapy offers advantages like faster healing, reduced pain and
inflammation, improved mobility and no requirement for donor sources or tissue
matching. The global Platelet Rich Plasma Market is estimated to be valued at
US$ 2.28 Bn in 2023 and is expected to exhibit a CAGR of 15.6% over the
forecast period 2023 to 2030, as highlighted in a new report published by
Coherent Market Insighats.
Market key trends:
Technological advancements have accelerated market growth. Various modified
techniques introduced by market leaders have automated the process of PRP
preparation with higher platelet yield and concentration levels. Advanced
machines facilitate faster and standardized preparation in minimal time without
manual errors. They also offer single-use sterile kits, integrated GPS systems
and wireless connectivity options for global monitoring of PRP therapy
treatments. This has simplified usage for physicians while improving the
efficacy of PRP therapy. Wider adoption across application areas and ongoing
research studies are further expanding market opportunities.
Segment
Analysis
The global platelet rich plasma market is segmented based on type, origin,
application, and end user. By type, the pure PRP segment dominates the market as
it is devoid of any elements other than platelets and growth factors. By
origin, the autologous PRP segment accounts for the largest share as it uses
patient's own blood, reducing the risk of transfusion-transmitted infections.
By application, the orthopedic surgery segment dominates as PRP is widely used
for muscle strain, joint pain, and ligament injuries by professional athletes
and sports medicine specialists. The aesthetic surgery segment is growing in
popularity due to rising demand for minimally invasive dermal fillers.
Hospitals & clinics are the largest end users segment due to availability
of advanced surgical and diagnostic facilities.
Key Takeaways
The Global
Platelet Rich Plasma Market Demand is expected to witness high growth
during the forecast period of 2023 to 2030.
Regional
analysis shows North America dominates the market currently due to supportive
reimbursement policies and advanced healthcare infrastructure. However, Asia
Pacific is expected to witness the highest growth driven by the rising medical
tourism industry in countries such as India, Thailand and Singapore.
Key players operating in the platelet rich plasma market are Menlo Systems
GmbH, Luna Innovations, TOPTICA Photonics AG, Advantest Corporation, Bakman
Technologies LLC, Teravil Ltd, Terasense Group Inc., Gentec Electro-optics
Inc., HÜBNER GmbH & Co. KG, Microtech Instruments, Inc., TeraView Limited
and Batop GmbH. The global platelet rich plasma market is concentrated with few
large players innovating novel technologies and platforms. Strategic
collaborations between companies and healthcare providers are expected to drive
market revenue.
For more details on the report, Read- https://www.insightprobing.com/platelet-rich-plasma-market-size-and-share/
Get
more insights on this topic: https://shoutingstars.com/carbon-capture-and-storage-a-vital-climate-change-solution
Comments
Post a Comment